NCT07220525Recruiting
Disrupted Sleep and Concurrent Ectopy or Atrial Fibrillation
Source: ClinicalTrials.gov · Last updated 2 Oct 2026
Brief summary (registry, in English)
Whereas the available evidence mostly supports chronic sleep disruption as a risk factor for incident AF, less is known about the near-term risk of a discrete atrial fibrillation (AF) episode following a night of disrupted or poor-quality sleep. This prospective, randomized, case-crossover study aims to examine the acute effects of sleep disruption on clinically relevant cardiac ectopy pertinent to AF.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- First submitted
- 22 Oct 2025
- Start date
- 15 Dec 2025
- Primary completion date
- 1 Jun 2027
- Lead sponsor
- University of California, San Francisco
- Diseases
- Atrial fibrillation
- NCT number
- NCT07220525
What you commit to
- Study type: Interventional
- Planned participants: 100
- From 15 Dec 2025 to the primary completion date, 1 Jun 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Are currently taking class 1 or 3 anti-arrhythmic medications
Other illness
- Have a history of permanent AF or expected to have continuous AF throughout the study period
- Have congenital heart disease
Other
- Currently pregnant or trying to get pregnant
- Ventricular pacing \>40%
- Are unable to read or sign to provide informed consent
Who the study is looking for
- Are age 21 years or older
- Have a HGNS device implanted for obstructive sleep apnea and followed up at UCSF Health
- Are willing to abstain from using the upper airway stimulation device for no more than two consecutive days as instructed over the 14-day trial period
- Able and willing to provide written informed consent
Age in the registry: 21 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| UCSF Medical Center at Parnassus Coordinator of this site? Confirm its status | San Francisco | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.